pMAPK inhibition enhances PS bortezomibinduced cytotoxicity against multiple myeloma cells. Oncogene. Mitsiades CS, Mitsiades NS, MuMullan CJ, Poulaki V, Shringarpure R, Hideshima T, Akiyama M, Chauhan D, Munshi N, Gu X, Bailey C, Joseph M, Libermann TA, Richon VM, Marks PA, Anderson KC.